{"id":267147,"date":"2026-09-24T11:52:40","date_gmt":"2026-09-24T06:22:40","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=267147"},"modified":"2026-09-24T11:52:40","modified_gmt":"2026-09-24T06:22:40","slug":"why-neuland-laboratories-share-price-price-fall-2026-09-24","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/","title":{"rendered":"Neuland Laboratories (NEULANDLAB) Share Price Falls 2.03% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories (NEULANDLAB)<\/a> share price fell to Rs 22,037.6 today, down 2.03% from the previous close. Market cap was Rs 28,905.16 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;24 September 2026 at 11:49:19 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Neuland Laboratories fell 2.03% to Rs 22,037.60. The company\u2019s market capitalisation stands at Rs 28,905.16 crore, and today\u2019s move keeps Neuland Laboratories Share Price in focus.<\/p>\n<p>Neuland Laboratories Share Price declined today as the stock closed at Rs 22,037.60, down Rs 455.70 from the previous close of Rs 22,493.30. The fall of 2.03% came after the session opened at Rs 22,498.35 and moved between Rs 22,585.00 and Rs 21,984.05. With a market capitalisation of Rs 28,905.16 crore, Neuland Laboratories is a large cap company and the day\u2019s move is relevant for readers tracking Neuland Laboratories Share Price Today, Neuland Laboratories Stock News and Neuland Laboratories Share Price Fall. The supplied data confirms the price event, but it does not establish a company-specific catalyst. What can be verified is the exact move, the day\u2019s price range, the turnover of Rs 2.12 crore and the company\u2019s valuation and sector context, which together frame today\u2019s Neuland Laboratories Share Price Update.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Neuland_Laboratories_NEULANDLAB_Share_Price_Today_Price_Action_Analysis\" title=\"Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis\">Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Neuland_Laboratories_NEULANDLAB_Fundamental_Analysis\" title=\"Neuland Laboratories (NEULANDLAB) Fundamental Analysis\">Neuland Laboratories (NEULANDLAB) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Why_Investors_Are_Watching_Neuland_Laboratories\" title=\"Why Investors Are Watching Neuland Laboratories\">Why Investors Are Watching Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#About_Neuland_Laboratories\" title=\"About Neuland Laboratories\">About Neuland Laboratories<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Track_Neuland_Laboratories_Share_Price_on_Univest\" title=\"Track Neuland Laboratories Share Price on Univest\">Track Neuland Laboratories Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#Why_did_Neuland_Laboratories_Share_Price_fall_today\" title=\"Why did Neuland Laboratories Share Price fall today?\">Why did Neuland Laboratories Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#What_is_Neuland_Laboratories_Share_Price_today\" title=\"What is Neuland Laboratories Share Price today?\">What is Neuland Laboratories Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#What_is_the_market_capitalisation_of_Neuland_Laboratories\" title=\"What is the market capitalisation of Neuland Laboratories?\">What is the market capitalisation of Neuland Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#How_does_Neuland_Laboratories_compare_with_healthcare_peers\" title=\"How does Neuland Laboratories compare with healthcare peers?\">How does Neuland Laboratories compare with healthcare peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#What_do_Neuland_Laboratories_fundamental_ratios_show\" title=\"What do Neuland Laboratories fundamental ratios show?\">What do Neuland Laboratories fundamental ratios show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-neuland-laboratories-share-price-price-fall-2026-09-24\/#How_is_Neuland_Laboratories_positioned_in_the_pharmaceuticals_industry\" title=\"How is Neuland Laboratories positioned in the pharmaceuticals industry?\">How is Neuland Laboratories positioned in the pharmaceuticals industry?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_NEULANDLAB_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,037.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,493.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 455.70 (-2.03%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,498.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22,585<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 21,984.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.12 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28,905.16 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Neuland Laboratories Share Price Today opened slightly below the prior close at Rs 22,498.35 and then traded through an intraday range of Rs 22,585.00 to Rs 21,984.05 before ending at Rs 22,037.60. That left the stock Rs 455.70 lower than the previous close of Rs 22,493.30, a decline of 2.03% for the session. The turnover was Rs 2.12 crore. On a price basis, the stock finished below the opening level and also near the lower end of the day\u2019s range, which makes the fall visible in the session structure itself. The market-cap category supplied for Neuland Laboratories is Large Cap, and the market capitalisation of Rs 28,905.16 crore places the company well above the median in the peer set used later in this article. For readers tracking Neuland Laboratories Stock News, the key factual point is that today\u2019s decline happened without any verified company-specific explanation in the supplied data. That sets up the need to examine valuation and fundamentals alongside the share price movement.<\/p>\n<p>Neuland Laboratories Share Price is therefore best read as a same-day price fall with a clearly defined open, high, low and close rather than as a broader event story. The next step is to assess whether the company\u2019s valuation and financial ratios provide enough context to explain why the stock remains in focus in Neuland Laboratories News Today and broader healthcare stock updates.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Neuland_Laboratories_NEULANDLAB_Fundamental_Analysis\"><\/span><strong>Neuland Laboratories (NEULANDLAB) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28,905.16 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">57.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 387.98<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,575.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.15%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Profitability metrics are also strong in the supplied snapshot: ROE is 21.43% and ROCE is 27.5%. Those figures show the returns generated on shareholder equity and capital employed, respectively, and they help explain why Neuland Laboratories Stock Analysis often attracts attention beyond a single day\u2019s move. From a fundamentals perspective, the stock is not only a price story; it is also a valuation story. The mix of high P\/E, high P\/B, healthy EPS, strong ROE and strong ROCE makes Neuland Laboratories Share Price a stock that investors tend to evaluate through both earnings quality and multiple-based comparison. Neuland Laboratories Financial Results are not part of the supplied event catalyst, but the existing financial ratios are sufficient to provide context for the current Neuland Laboratories Share Price Today move. The next lens is ownership context, although the supplied ownership snapshot does not add percentages here, so the focus shifts naturally to sector and peer benchmarks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">57.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">50.01x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.48x to 762.66x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.38x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.43%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.5%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.26%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 28,905.16 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 761.61 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,299.75 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Neuland Laboratories operates in Healthcare within the Pharmaceuticals &#038; Drugs industry, and the supplied benchmark universe covers the same industry with 200 companies. In that benchmark set, the company\u2019s P\/E of 57.98 is above the median of 31.9 and above the average of 50.01, while remaining far below the maximum of 762.66. Its P\/B of 14.28 is well above the median of 3 and also above the average of 4.38. ROE at 21.43% is above the benchmark median of 11.7% and average of 10.65%, and ROCE at 27.5% is above the benchmark median of 13.46% and average of 13.26%.<\/p>\n<p>The sector benchmark also shows market capitalisation context: the median market cap in the same industry is Rs 761.61 crore, the average is Rs 14,299.75 crore, and the company\u2019s market cap of Rs 28,905.16 crore is above both. That makes Neuland Laboratories Share Price a large-company valuation story within the pharmaceuticals space rather than a smaller company comparison. Sector analysis therefore points to a stock that is priced materially above the industry median on valuation multiples while also showing stronger-than-benchmark profitability ratios. Neuland Laboratories Share Price News today should be read against that backdrop, because the day\u2019s decline sits inside a broader valuation conversation rather than an isolated operating metric. For readers asking why Neuland Laboratories is trending, the verified answer is that the stock combines a same-day fall with higher-than-benchmark profitability and premium valuation ratios in a large-cap healthcare setting.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,42,437.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,48,053.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,841.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,15,810.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,11,565.25<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Among the supplied peers, Neuland Laboratories Share Price sits above most of the listed market capitalisations in this group. Its Rs 28,905.16 crore market cap is below Sun Pharmaceutical Industries at Rs 4,42,437.37 crore and Divi\u2019s Laboratories at Rs 2,48,053.84 crore, but above Torrent Pharmaceuticals at Rs 1,89,841.60 crore, Zydus Lifesciences at Rs 1,15,810.19 crore and Cipla at Rs 1,11,565.25 crore. On valuation, Neuland\u2019s P\/E of 57.98 is higher than Sun Pharma\u2019s 37 and Cipla\u2019s 33.08, but lower than Divi\u2019s 87.1 and Torrent\u2019s 86.85. Its P\/B of 14.28 is well above Sun Pharma, Zydus Lifesciences and Cipla, though still below Torrent\u2019s 21.1 and slightly below Divi\u2019s 14.42.<\/p>\n<p>On profitability, Neuland\u2019s ROE of 21.43% is above Sun Pharma, Divi\u2019s and Cipla, but below Torrent and Lupin among the broader peer set used in the dataset. Its ROCE of 27.5% is also strong relative to most peers, exceeded only by Lupin\u2019s 28.86% in the broader comparison and close to Torrent\u2019s 19.27% and Divi\u2019s 21.51% on the supplied list. For Neuland Laboratories Share Price Today, the peer set suggests a company with a premium valuation and strong return ratios rather than a low-multiple stock. That is important for Neuland Laboratories Stock News because it frames today\u2019s fall against a backdrop of valuation depth and industry comparison rather than a simple standalone decline.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Neuland_Laboratories\"><\/span><strong>Why Investors Are Watching Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Neuland Laboratories Share Price fell 2.03% today to Rs 22,037.60 after closing at Rs 22,493.30 previously.<\/li>\n<li>The day\u2019s price range was Rs 21,984.05 to Rs 22,585.00, with turnover of Rs 2.12 crore.<\/li>\n<li>The company\u2019s market capitalisation stands at Rs 28,905.16 crore, and the market-cap category supplied is Large Cap.<\/li>\n<li>Neuland Laboratories has a P\/E of 57.98, a P\/B of 14.28, ROE of 21.43% and ROCE of 27.5%.<\/li>\n<li>In the same industry benchmark, the company\u2019s P\/E, P\/B, ROE and ROCE are above the median values.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Neuland_Laboratories\"><\/span><strong>About Neuland Laboratories<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Neuland Laboratories belongs to the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. The supplied dataset identifies the company through these classifications and supports a market-cap view of Rs 28,905.16 crore. For Neuland Laboratories Share Price readers, that classification matters because the stock is being compared with other listed pharmaceutical companies in the same industry benchmark and peer set. Neuland Laboratories Company News often appears in the context of market performance, valuation and sector comparison, and today\u2019s event fits that pattern. The verified data in this article does not include a product mix or detailed business description, so the available company view remains focused on sector identity, industry bucket and financial metrics. That is still enough to place today\u2019s Neuland Laboratories Share Price fall into a useful research frame for Neuland Laboratories Latest News and Neuland Laboratories Stock Performance tracking.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Neuland_Laboratories_Share_Price_on_Univest\"><\/span><strong>Track Neuland Laboratories Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/neulandlab\/neuland-laboratories-ltd-share-price-today\">Neuland Laboratories (NEULANDLAB) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Readers can follow Neuland Laboratories Share Price on Univest for live price updates, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Neuland Laboratories Share Price Today, Neuland Laboratories Stock News and comparison data in one place so users can review the company alongside its sector and peers.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Neuland_Laboratories_Share_Price_fall_today\"><\/span><strong>Why did Neuland Laboratories Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The supplied data confirms that Neuland Laboratories Share Price fell 2.03% today, but it does not establish a company-specific catalyst. The verified facts are the close of Rs 22,037.60, the prior close of Rs 22,493.30 and the day\u2019s price range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Neuland_Laboratories_Share_Price_today\"><\/span><strong>What is Neuland Laboratories Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories Share Price today is Rs 22,037.60. It is down Rs 455.70 from the previous close of Rs 22,493.30, and the session\u2019s high and low were Rs 22,585.00 and Rs 21,984.05 respectively.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Neuland_Laboratories\"><\/span><strong>What is the market capitalisation of Neuland Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories has a market capitalisation of Rs 28,905.16 crore. The supplied market-cap category is Large Cap, and that size context is useful when comparing the stock with other pharmaceuticals companies in the same industry.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Neuland_Laboratories_compare_with_healthcare_peers\"><\/span><strong>How does Neuland Laboratories compare with healthcare peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories trades at a higher P\/E than several peers such as Sun Pharma and Cipla, while its ROE and ROCE are also above the industry benchmark median. That places its valuation and profitability in a premium bracket.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Neuland_Laboratories_fundamental_ratios_show\"><\/span><strong>What do Neuland Laboratories fundamental ratios show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Neuland Laboratories has a P\/E of 57.98, a P\/B of 14.28, EPS of Rs 387.98, book value of Rs 1,575.41 and dividend yield of 0.15%. ROE is 21.43% and ROCE is 27.5%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Neuland_Laboratories_positioned_in_the_pharmaceuticals_industry\"><\/span><strong>How is Neuland Laboratories positioned in the pharmaceuticals industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;In the same industry benchmark of 200 companies, Neuland Laboratories is above the median on P\/E, P\/B, ROE and ROCE. That makes the stock notable in Pharmaceuticals &amp; Drugs within the Healthcare sector.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Neuland Laboratories Share Price falls to Rs 22,037.6. marking a 2.03% fall today. Market cap stands at Rs 28,905.16 crore.<\/p>\n","protected":false},"author":29,"featured_media":267144,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-267147","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["267144"],"rank_math_title":["Neuland Laboratories Share Price Fall: Price Action Review"],"rank_math_description":["Neuland Laboratories Share Price fell 2.03% to Rs 22,037.60. Read today\u2019s price action, fundamentals, sector comparison and peer context."],"rank_math_focus_keyword":["Neuland Laboratories Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/neuland-laboratories-neulandlab-share-price-falls-2-03-today.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/267147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=267147"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/267147\/revisions"}],"predecessor-version":[{"id":267148,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/267147\/revisions\/267148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/267144"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=267147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=267147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=267147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}